Suppr超能文献

伯氏疏螺旋体B31外表面蛋白C保护性表位的构象性质

Conformational nature of the Borrelia burgdorferi B31 outer surface protein C protective epitope.

作者信息

Gilmore R D, Mbow M L

机构信息

Division of Vector-Borne Infectious Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Public Health Service, U.S. Department of Health and Human Services, Fort Collins, Colorado 80522, USA.

出版信息

Infect Immun. 1999 Oct;67(10):5463-9. doi: 10.1128/IAI.67.10.5463-5469.1999.

Abstract

Active immunization with Escherichia coli-expressed recombinant outer surface protein C (OspC) of Borrelia burgdorferi has been demonstrated to confer protection against a tick-transmitted infection on laboratory animals. A previous study in this laboratory showed that OspC antibody raised against a denatured immunogen isolated from B. burgdorferi cells failed to provide protective immunity. Therefore, to determine whether the protective epitope of the recombinant antigen was sensitive to denaturation, recombinant OspC preparations were subjected to heat and chemical treatments prior to animal immunization. Following seroconversion to OspC, the animals were challenged with an infectious dose of B. burgdorferi B31 by tick bite. Whereas mice immunized with a soluble, nondenatured form continued to show protection rates close to 100%, mice that had been immunized with denatured antigen were not protected. Furthermore, mice that were immunized with an insoluble (rather than a soluble), nondenatured form of the recombinant OspC showed a protection rate of only 40%. Protective epitope localization experiments showed that either the amino or the carboxy end of the recombinant protein was required to react with a protective OspC-specific monoclonal antibody. The data from these experiments demonstrate that a conformational organization of the protein is essential for the protective capability of the strain B31 OspC immunogen.

摘要

用大肠杆菌表达的伯氏疏螺旋体重组外表面蛋白C(OspC)进行主动免疫已被证明能使实验动物免受蜱传播感染。本实验室先前的一项研究表明,针对从伯氏疏螺旋体细胞中分离出的变性免疫原产生的OspC抗体不能提供保护性免疫。因此,为了确定重组抗原的保护性表位是否对变性敏感,在动物免疫前对重组OspC制剂进行了加热和化学处理。在血清转化为OspC后,通过蜱叮咬用感染剂量的伯氏疏螺旋体B31攻击动物。用可溶性、非变性形式免疫的小鼠继续显示接近100%的保护率,而用变性抗原免疫的小鼠则没有得到保护。此外,用重组OspC的不溶性(而非可溶性)、非变性形式免疫的小鼠显示的保护率仅为40%。保护性表位定位实验表明,重组蛋白的氨基端或羧基端需要与保护性OspC特异性单克隆抗体反应。这些实验的数据表明,蛋白质的构象组织对于菌株B31 OspC免疫原的保护能力至关重要。

相似文献

1
Conformational nature of the Borrelia burgdorferi B31 outer surface protein C protective epitope.
Infect Immun. 1999 Oct;67(10):5463-9. doi: 10.1128/IAI.67.10.5463-5469.1999.
4
Enhanced Protective Immunogenicity of Homodimeric Borrelia burgdorferi Outer Surface Protein C.
Clin Vaccine Immunol. 2017 Jan 5;24(1). doi: 10.1128/CVI.00306-16. Print 2017 Jan.
7
Cross-reactive acquired immunity influences transmission success of the Lyme disease pathogen, Borrelia afzelii.
Infect Genet Evol. 2015 Dec;36:131-140. doi: 10.1016/j.meegid.2015.09.012. Epub 2015 Sep 16.
9
Evasion of protective immunity by Borrelia burgdorferi by truncation of outer surface protein B.
Proc Natl Acad Sci U S A. 1993 May 1;90(9):4092-6. doi: 10.1073/pnas.90.9.4092.

引用本文的文献

1
Possible effect of mutations on serological detection of Borrelia burgdorferi sensu stricto ospC major groups: An in-silico study.
PLoS One. 2023 Oct 10;18(10):e0292741. doi: 10.1371/journal.pone.0292741. eCollection 2023.
3
Maximum antigen diversification in a lyme bacterial population and evolutionary strategies to overcome pathogen diversity.
ISME J. 2022 Feb;16(2):447-464. doi: 10.1038/s41396-021-01089-4. Epub 2021 Aug 19.
4
Human and Veterinary Vaccines for Lyme Disease.
Curr Issues Mol Biol. 2021;42:191-222. doi: 10.21775/cimb.042.191. Epub 2020 Dec 8.
5
Development and optimization of OspC chimeritope vaccinogens for Lyme disease.
Vaccine. 2020 Feb 18;38(8):1915-1924. doi: 10.1016/j.vaccine.2020.01.027. Epub 2020 Jan 17.
8
Epitope mapping of Borrelia burgdorferi OspC protein in homodimeric fold.
Protein Sci. 2017 Apr;26(4):796-806. doi: 10.1002/pro.3125. Epub 2017 Feb 11.
10
Evaluation of the Borrelia burgdorferi BBA64 protein as a protective immunogen in mice.
Clin Vaccine Immunol. 2014 Apr;21(4):526-33. doi: 10.1128/CVI.00824-13. Epub 2014 Feb 5.

本文引用的文献

8
Therapeutic passive vaccination against chronic Lyme disease in mice.
Proc Natl Acad Sci U S A. 1997 Nov 11;94(23):12533-8. doi: 10.1073/pnas.94.23.12533.
9
Borrelia burgdorferi strain-specific Osp C-mediated immunity in mice.
Infect Immun. 1997 Nov;65(11):4661-7. doi: 10.1128/iai.65.11.4661-4667.1997.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验